# The latest drugs for high blood pressure # --- [](https://cardio-balance-ph.store-best.net) <div style="height:500px;"></div> ## The most dangerous of cardiovascular diseases ## Nililinis ang mga ugat na kailangang alagaan mula sa deposito at pinananatili ang kinakailangang lakas ng tibok ng puso! The most dangerous heart disease: A silent threat Cardiovascular diseases are among the leading causes of death worldwide, and unfortunately, these Sad statistics does not take a downturn. According to the world health organization (WHO), cases a year, billions of deaths, often even before the individuals perceive the first serious symptoms. But which of these diseases are considered to be particularly dangerous? 1. Heart Attack (Myocardial Infarction) The heart attack is at the forefront of the most dangerous diseases. It occurs when blood flow to a part of the heart is suddenly interrupted — usually by a blood clot in a coronary artery. Without quick treatment, the affected heart muscle tissue dies. The symptoms may include pain, severe chest, shortness of breath and Nausea, but sometimes a heart attack is also barely noticeable — especially in the case of women or diabetics. 2. Stroke (Apoplexy) A stroke occurs when the blood supply is interrupted to the brain, either by a blockage (ischemic stroke) or bleeding (hemorrhagic stroke). The consequences are disastrous: paralysis, speech disturbances, memory loss, and often a life-long disability. Here, too, the chances of a full recovery, the following applies: The faster the treatment begins, the better. 3. Heart failure In heart failure, the heart loses its pumping capacity, it can supply the body tissues with enough oxygen. The disease often develops slowly and leads to fatigue, water retention (Edema) and shortness of breath with exertion. Although it is rarely the direct cause of Death, it lowers the quality of life dramatically and increases the risk for further complications. 4. Arrhythmias (Heart Rhythm Disorders) Not every rhythm disturbance of the heart is dangerous, but certain forms of ventricular fibrillation (ventricular fibrillation) may lead within minutes of sudden cardiac death. The heart twitches uncoordinated and pumping of blood. A Defibrillator can be lifesaving, but only if it is used in time. 5. Atherosclerosis Atherosclerosis, calcification and hardening of the arteries, is the basis of many cardiovascular problems. It has developed over the years, often unnoticed, and leads to a restriction of the blood supply in all regions of the body. Its consequences range from heart attacks to peripheral arterial disease, which can lead, in extreme cases, to amputation. Prevention: The best cure Many of these diseases through healthy lifestyle can significantly reduce. Regular physical activity, a balanced diet low in salt and saturated fats, the waiver of Smoking and how to deal with Stress, reduce the risk significantly. The regular Checking of blood pressure, cholesterol and blood sugar levels can reveal dangerous developments at an early stage. Cardiovascular diseases are dangerous, but not unavoidable. With awareness and Prevention, we can protect ourselves against the silent threat — and our hearts for many years to get healthy. All ingredients, such as garlic and cinnamon bark in Cardio Balance, have proved to reduce blood pressure. The combination of these ingredients in the right quantity has shown massive improvement in managing blood pressure. > Kasabay nito, hindi inirerekomenda ang pangmatagalang pag-inom ng mga gamot mula sa kategoryang Diuretics, dahil ang mahahalagang sangkap tulad ng Potassium, Calcium, Magnesium ay mabilis na nailalabas sa katawan kasama ng sobrang tubig at asin. Alinsunod sa katangiang ito, sinasabayan ng mga Diuretics ang pag-inom ng mga gamot na may laman ng mga sangkap na ito. Maaaring ito ay mga vitamin at mineral na complexes, monokomponent, o mga suplemento sa pagkain na may napatunayang klinikal na bisa.  <a href="https://hedge.grin.hu/s/x21grXvwca">https://hedge.grin.hu/s/x21grXvwca</a> Ang arteryal na hypertension o hypertension ay isang kondisyon ng patuloy na systolic at diastolic na presyon ng dugo, kung saan ang mga sukatan ay lumalagpas sa 140/90 mmHg. Ang mataas na presyon ay nagpapakita ng mga hindi komportableng sintomas. <a href="https://pad.fablab-siegen.de/s/JKdK_yCHzd">PUMUNTA SA WEBSITE>>> </a> The latest drugs for high blood pressure High blood pressure, known medically as hypertension referred to, it represents a failure of a worldwide health problem and is considered to be one of the main risk factors for cardiovascular disease, including heart attack, stroke, and kidney. The continuous development of pharmacological therapy aims to lower the blood pressure effectively and to minimize the side effects. Current Medications Categories The current guidelines recommend the use of several classes of antihypertensive drugs as first choice. To include the latest developments, in particular: ARNi (Angiotensin Receptor Neprilysin Inhibitors) A prominent example of Sacubitril/Valsartan, a combination of a Neprilysin inhibitor and an Angiotensin‑II‑receptor antagonists. This drug showed in studies with a superior efficacy compared to conventional ACE inhibitors in patients with concomitant congestive heart failure. It promotes Natriuresis and vasodilation and thus lowers the blood pressure effectively. Endothelin Receptor Antagonists For special groups of patients, particularly in resistant hypertension, or in the case of simultaneous pulmonary hypertension, the investigation of such substances. They block the action of Endothelin 1, a powerful vasoconstrictor and leads to a blood vessel enlargement. Inhibitors of the mineralocorticoid receptor (MRAs) New selective MRAs as Finerenon are specifically designed for patients with type 2 Diabetes mellitus and chronic kidney disease developed. They not only reduce the blood pressure, but also protect the kidney function. Antisense oligonucleotides against Angiotensinogen This innovative therapeutic strategy aims at the reduction of the synthesis of Angiotensinogen in the liver. In early clinical studies, these substances showed a significant reduction in blood pressure after just one injection, which is a promising Option for patients with poor medication compliance. Monoclonal antibodies to Renin or other target structures Experimental approaches include monoclonal antibodies, which inhibit specific components of the Renin‑Angiotensin‑aldosterone system (RAAS). These drugs offer a longer duration of action and may have fewer side effects than conventional oral preparations. Clinical evidence and perspectives The latest studies, including the PARADIGM‑HF and FIDELIO‑DKD‑study confirm the efficacy and safety of these new substances. In particular, Sacubitril/Valsartan led to a significant reduction of cardiovascular deaths and hospitalizations in patients with heart failure. Despite the promising results, the challenges remain: Cost of new therapies; Long-term data on the safety; Identification of the optimal patient groups; possible interactions with other medications. Conclusion The development of new drugs against hypertension offers significant opportunities to improve patient care. In particular, the combination of different mechanisms of action and the introduction of innovative substances, such as Antisense therapeutics and monoclonal antibodies could in the future to revolutionize the treatment of resistant and komorbidem high blood pressure. Further research and long-term observational studies are necessary, however, to the full potential of these new therapies exploit. Would you like me to make a certain section in greater detail or further Details about a specific class of drugs to add? ## For high blood pressure with minimal side effects ## For high blood pressure with least side effects: modern approaches in anti-hypertensive therapy High blood pressure (arterial hypertension) is one of the most common chronic diseases worldwide and a major risk factor for cardiovascular diseases such as heart attack, stroke, and kidney damage. The objective of the therapy is not only in the lowering of blood pressure to normal values (&lt;140/90 mmHg, or in the case of high-risk patients &lt;130/80 mmHg), but also the minimization of side effects, in order to ensure the long-term patient compliance. Therapeutic strategies with low side effects Modern guidelines recommend as a first choice for several classes of antihypertensive agents have good efficacy and a favorable side-effect profile: ACE inhibitors (e.g., Ramipril, Perindopril): Act by inhibition of the angiotensin‑converting enzyme, which leads to vasodilation. Side effects (such as cough or Hyperkalemia) are relatively rare and are most pronounced in the mild. Evidence for organ protection function (heart, kidneys). AT1‑Receptor antagonists (Sartans) (e.g., Losartan, Valsartan): Similar efficacy to ACE inhibitors, but with a lower incidence of cough. Well tolerated, especially in patients who cannot tolerate ACE inhibitors. Calcium channel blockers (Dihydropyridines, such as amlodipine): Effective in isolated systolic hypertension in older age. Side effects such as Edema, or headaches are dose-dependent and often by adjusting the dose to control. Thiazide‑like diuretics (such as Chlorthalidone, indapamide): Low doses lead to an effective reduction in blood pressure with minimal metabolic side effects. Indapamide is characterized by a particularly favorable tolerability. Beta-blockers with vasodilating properties (e.g. Nebivolol): Are particularly suitable for patients with concurrent coronary artery disease or congestive heart failure. The vasodilating effect is reduced, typical side effects such as coldness of the extremities. Individual therapy adjustment is the key to success The greatest effectiveness and minimal side-effect of the load is achieved by means of individual therapy, the following factors into account: Age and gender of the patient; The presence of Comorbidities (Diabetes, kidney disease, congestive heart failure); Genetic predisposition to certain side effects; Style factors (salt intake, weight, physical activity) life. Preventive measures, as the Basis Drug therapy should be supported by non‑pharmacological measures: Weight reduction in Overweight; Change in diet the DASH diet model (rich in vegetables, fruits, low salt content); Regular physical activity (at least 150 minutes of moderate aerobics per week); Reduction of alcohol consumption; Avoidance of Smoking. Conclusion The use of modern antihypertensive drugs in low or medium doses, optionally in combination therapy, and provides effective blood pressure control with minimal side effects. A patient-centered approach, the life-style changes including, leads to a long-term improvement in prognosis and quality of life of patients with hypertension. <a href="https://hedgedoc.obermui.de/s/hbF_SyLfLx">For high blood pressure with minimal side effects</a> The latest drugs for high blood pressure. <a href="https://hedgedoc.private.coffee/s/fu5sLiEcT">The most dangerous of cardiovascular diseases</a> <a href="https://pad.yuka.dev/s/bIMUOtZU9I">For high blood pressure with minimal side effects</a> <a href="https://hedgedoc.jcg.re/s/5QqwGMP-1k">Gymnastics of hypertension with Signal</a> <a href="https://notas.gaiacoop.tech/s/THN4Dgv-Q">https://notas.gaiacoop.tech/s/THN4Dgv-Q</a> <a href="https://hedgedoc.digilol.net/s/IxN0wMpEY0">https://hedgedoc.digilol.net/s/IxN0wMpEY0</a> <a href="https://hedgedoc.private.coffee/s/vcg_q_2nY">https://hedgedoc.private.coffee/s/vcg_q_2nY</a> <a href="https://docs.localcharts.org/s/NS9fZBOXd">https://docs.localcharts.org/s/NS9fZBOXd</a> <a href="https://pad.koeln.ccc.de/s/yVuD9Jnqh">https://pad.koeln.ccc.de/s/yVuD9Jnqh</a> <a href="https://pad.mytga.de/s/-wURkChRh">https://pad.mytga.de/s/-wURkChRh</a> <a href="https://md.sigma2.no/s/K97iRQZRQ">https://md.sigma2.no/s/K97iRQZRQ</a> <a href="https://hedgedoc.et.aksw.org/s/sRCK3I0ql">https://hedgedoc.et.aksw.org/s/sRCK3I0ql</a> <a href="https://doc.fsr.saarland/s/6U5CqvmtJK">https://doc.fsr.saarland/s/6U5CqvmtJK</a> <a href="https://hedgedoc.auro.re/s/uN-aemuubB">https://hedgedoc.auro.re/s/uN-aemuubB</a> <a href="https://pad.multiplace.org/s/Bk5LBjdzGg">https://pad.multiplace.org/s/Bk5LBjdzGg</a> <a href="https://md.giplt.nl/s/as8Flb55eZ">https://md.giplt.nl/s/as8Flb55eZ</a> <a href="https://hedgedoc.ichmann.de/s/nrcduEpbV5">https://hedgedoc.ichmann.de/s/nrcduEpbV5</a> <a href="https://notes.rabjerg.de/s/S1SvHo_zfl">https://notes.rabjerg.de/s/S1SvHo_zfl</a> <a href="https://pad.medialepfade.net/s/z4G-D4pAY">https://pad.medialepfade.net/s/z4G-D4pAY</a> <a href="https://pad.sra.uni-hannover.de/s/yAbwjTE6OX">https://pad.sra.uni-hannover.de/s/yAbwjTE6OX</a> <a href="https://dok.kompot.si/s/rVraQM_g5H">https://dok.kompot.si/s/rVraQM_g5H</a> <a href="https://md.coredump.ch/s/8KqB_Uzl6">https://md.coredump.ch/s/8KqB_Uzl6</a> <a href="https://edit.leiden.digital/s/mNjY6gWBbQ">https://edit.leiden.digital/s/mNjY6gWBbQ</a> <a href="https://notas.laotra.red/s/eWe-unbmts">https://notas.laotra.red/s/eWe-unbmts</a> <a href="https://doc.spiegie.de/s/NiAEGD9dc">https://doc.spiegie.de/s/NiAEGD9dc</a> <a href="https://md.sebastians.dev/s/Z2cnia8_M">https://md.sebastians.dev/s/Z2cnia8_M</a> <a href="https://hedgedoc.private.coffee/s/7KzKv5vjX">https://hedgedoc.private.coffee/s/7KzKv5vjX</a> <a href="https://hedgedoc.nrp-nautilus.io/s/EDAWrbVpXd">https://hedgedoc.nrp-nautilus.io/s/EDAWrbVpXd</a> <a href="https://md.mandragot.org/s/EHFjW519qA">https://md.mandragot.org/s/EHFjW519qA</a> <a href="https://doc.neutrinet.be/s/dRfayGZ4AP">https://doc.neutrinet.be/s/dRfayGZ4AP</a> <a href="https://hedgedoc.inqbus.de/s/oI4MJATxW">https://hedgedoc.inqbus.de/s/oI4MJATxW</a> <a href="https://doc.gnuragist.es/s/mNfLEd0YRM">https://doc.gnuragist.es/s/mNfLEd0YRM</a> <a href="https://pad.cttue.de/s/jvhRm4BCw">https://pad.cttue.de/s/jvhRm4BCw</a> <a href="https://pad.demokratie-dialog.de/s/FgoLB0ffnN">https://pad.demokratie-dialog.de/s/FgoLB0ffnN</a> <a href="https://omoffice.de/s/ByjiHoOMfg">https://omoffice.de/s/ByjiHoOMfg</a> <a href="https://pad.n39.eu/s/k78zqkRrfq">https://pad.n39.eu/s/k78zqkRrfq</a> <a href="https://doc.projectsegfau.lt/s/wVI810YM80">https://doc.projectsegfau.lt/s/wVI810YM80</a> <a href="https://md.interhacker.space/s/z_bJ_W1lzo">https://md.interhacker.space/s/z_bJ_W1lzo</a> <a href="https://md.nolog.cz/s/BvCKgv-vK">https://md.nolog.cz/s/BvCKgv-vK</a> <a href="https://hack.utopia-lab.org/s/jBUQnh7k2">https://hack.utopia-lab.org/s/jBUQnh7k2</a> <a href="https://hdoc.csirt-tooling.org/s/5D-GZ2A7Vi">https://hdoc.csirt-tooling.org/s/5D-GZ2A7Vi</a> <a href="https://pad.dominick-leppich.de/s/6zOadW2xX">https://pad.dominick-leppich.de/s/6zOadW2xX</a> <a href="https://doc.fung.uy/s/icaW4MmA5q">https://doc.fung.uy/s/icaW4MmA5q</a> <a href="https://pads.dgnum.eu/s/AgfVUlmN2D">https://pads.dgnum.eu/s/AgfVUlmN2D</a> <a href="https://doc.interscalar.eu/s/FT95wgNrA">https://doc.interscalar.eu/s/FT95wgNrA</a> <a href="https://md.globenet.org/s/JySGEEnN6">https://md.globenet.org/s/JySGEEnN6</a> <a href="https://hedgedoc.obermui.de/s/RhTS-OL7bt">https://hedgedoc.obermui.de/s/RhTS-OL7bt</a> <a href="https://hedgedoc.jcg.re/s/EAZECw8CEk">https://hedgedoc.jcg.re/s/EAZECw8CEk</a> <a href="https://pad.gusted.xyz/s/dmoteae0-">https://pad.gusted.xyz/s/dmoteae0-</a> <a href="https://doc.interscalar.eu/s/j_DGT0HVE">https://doc.interscalar.eu/s/j_DGT0HVE</a> <a href="https://hedgedoc.team23.org/s/crMjVDeNvk">https://hedgedoc.team23.org/s/crMjVDeNvk</a> <a href="https://hedge.amosamos.net/s/8a9D_Ch3aY">https://hedge.amosamos.net/s/8a9D_Ch3aY</a> <a href="https://hedgedoc.stanleysolutionsnw.com/s/XVKISs_Mqq">https://hedgedoc.stanleysolutionsnw.com/s/XVKISs_Mqq</a> <a href="https://notas.gaiacoop.tech/s/gcte2Hr18">https://notas.gaiacoop.tech/s/gcte2Hr18</a> <a href="https://www.notizen.kita.bayern/s/jqIXx6Cxfu">https://www.notizen.kita.bayern/s/jqIXx6Cxfu</a> <a href="https://pad.ccc-p.org/s/AxZ0JzSNF3">https://pad.ccc-p.org/s/AxZ0JzSNF3</a> <a href="https://pad.fablab-siegen.de/s/Y_nIw-tGfq">https://pad.fablab-siegen.de/s/Y_nIw-tGfq</a> <a href="https://pads.cantorgymnasium.de/s/WHn9tK-2G">https://pads.cantorgymnasium.de/s/WHn9tK-2G</a> <a href="https://notes.simeonreusch.com/s/GQXfj9MMh">https://notes.simeonreusch.com/s/GQXfj9MMh</a> <a href="https://md.infs.ch/s/cH18SJry0E">https://md.infs.ch/s/cH18SJry0E</a> <a href="https://md.cortext.net/s/QWWJ82Tlh">https://md.cortext.net/s/QWWJ82Tlh</a> <a href="https://doc.cisti.org/s/SvOK8Xz0ER">https://doc.cisti.org/s/SvOK8Xz0ER</a> <a href="https://hd.wedler.me/s/htf4u9xsP">https://hd.wedler.me/s/htf4u9xsP</a> <a href="https://write.frame.gargantext.org/s/rkW2XjuMMl">https://write.frame.gargantext.org/s/rkW2XjuMMl</a> <a href="https://md.gafert.org/s/eIZSaXdPr">https://md.gafert.org/s/eIZSaXdPr</a> <a href="https://md.eris.cc/s/zcMzKTASTV">https://md.eris.cc/s/zcMzKTASTV</a> <a href="https://md.micronited.de/s/r1xWUs_ffg">https://md.micronited.de/s/r1xWUs_ffg</a> <a href="https://pad.mytga.de/s/wwHk05-5T">https://pad.mytga.de/s/wwHk05-5T</a> <a href="https://md.softwarefreedom.net/s/Vb88CJMrf">https://md.softwarefreedom.net/s/Vb88CJMrf</a> <a href="https://pad.aleph.world/s/m_xXruQHl">https://pad.aleph.world/s/m_xXruQHl</a> <a href="https://notes.llgoewer.de/s/nHyfZdIsq">https://notes.llgoewer.de/s/nHyfZdIsq</a> <a href="https://hedgedoc.et.aksw.org/s/PWb605Och">https://hedgedoc.et.aksw.org/s/PWb605Och</a> <a href="https://om-office.de/s/SJgMUi_GMx">https://om-office.de/s/SJgMUi_GMx</a> <a href="https://pad.nantes.cloud/s/5aK3rGUd-Z">https://pad.nantes.cloud/s/5aK3rGUd-Z</a> <a href="https://doc.fsr.saarland/s/6Yr3HqgPtX">https://doc.fsr.saarland/s/6Yr3HqgPtX</a> <a href="https://md.coredump.ch/s/5Yk1Lmy3B">https://md.coredump.ch/s/5Yk1Lmy3B</a> <a href="https://hackmd.k15.synology.me/s/2fxCMl3bV">https://hackmd.k15.synology.me/s/2fxCMl3bV</a> <a href="https://pad.hxx.cz/s/IpBqVmyU7P">https://pad.hxx.cz/s/IpBqVmyU7P</a> <a href="https://doc.hkispace.com/s/PBD1ORhbq">https://doc.hkispace.com/s/PBD1ORhbq</a> <a href="https://codi.sevenvm.de/s/qu_b3YVst">https://codi.sevenvm.de/s/qu_b3YVst</a> <a href="https://n.jo-so.de/s/GKwCNKsFd">https://n.jo-so.de/s/GKwCNKsFd</a> <a href="https://hedge.grin.hu/s/j8YAX0kllG">https://hedge.grin.hu/s/j8YAX0kllG</a> <a href="https://pad.yuka.dev/s/8h1eA-tYxf">https://pad.yuka.dev/s/8h1eA-tYxf</a> <a href="https://hedgedoc.ichmann.de/s/lbiN343mZH">https://hedgedoc.ichmann.de/s/lbiN343mZH</a> <a href="https://docs.snowdrift.coop/s/L4p7e3LeF">https://docs.snowdrift.coop/s/L4p7e3LeF</a> <a href="https://hedgedoc.ffmuc.net/s/DMPG6OAqoF">https://hedgedoc.ffmuc.net/s/DMPG6OAqoF</a> <a href="https://pad.medialepfade.net/s/OyjppC-Qv">https://pad.medialepfade.net/s/OyjppC-Qv</a> <a href="https://pads.tobast.fr/s/rTwk8-rOue">https://pads.tobast.fr/s/rTwk8-rOue</a> <a href="https://hedgedoc.digilol.net/s/VLz1VYBzcZ">https://hedgedoc.digilol.net/s/VLz1VYBzcZ</a> <a href="https://docs.localcharts.org/s/SWWIgeA7a">https://docs.localcharts.org/s/SWWIgeA7a</a> <a href="https://hedgedoc.syyrell.com/s/akZrbwLelx">https://hedgedoc.syyrell.com/s/akZrbwLelx</a> <a href="https://hedgedoc.private.coffee/s/QRSpcjDFe">https://hedgedoc.private.coffee/s/QRSpcjDFe</a> <a href="https://pad.koeln.ccc.de/s/ldWxd0tks">https://pad.koeln.ccc.de/s/ldWxd0tks</a> <a href="https://doc.hkispace.com/s/Q90AwwfFD">https://doc.hkispace.com/s/Q90AwwfFD</a> <a href="https://md.sigma2.no/s/22_gG8Q20">https://md.sigma2.no/s/22_gG8Q20</a> <a href="https://notas.laotra.red/s/MmorRJHPkf">https://notas.laotra.red/s/MmorRJHPkf</a> <a href="https://doc.neutrinet.be/s/PhVJ2TELMj">https://doc.neutrinet.be/s/PhVJ2TELMj</a> <a href="https://md.giplt.nl/s/EulM3D3hxW">https://md.giplt.nl/s/EulM3D3hxW</a> <a href="https://pad.mytga.de/s/9VW_U08Lg">https://pad.mytga.de/s/9VW_U08Lg</a> <a href="https://hedgedoc.auro.re/s/MY-7eYhau6">https://hedgedoc.auro.re/s/MY-7eYhau6</a> ## Gymnastics of hypertension with Signal ## The Shishonina Gymnastics: A new way to fight high blood pressure? High blood pressure, medically called hypertension, is a silent Killer: he Often runs over the years, hardly noticeable damage but the heart, kidneys and blood vessels. According to studies, around 20 million people in Germany suffer from this risk factor. In addition to medication and lifestyle changes, alternative methods are discussed, including the so-called Shishonina Gymnastics. What lies behind this method? The Shishonina Gymnastics dates back to the Russian Doctor and physical therapist Irina Shishonina. Her approach combines gentle movement sequences, breathing techniques and relaxation exercises. In contrast to high-intensity sports performance, but the harmonization of the body is in the foreground. How to help against high blood pressure? Supporters of the method argue that the regular execution of the Exercises can exert the following effects: Reduce stress levels: Through targeted breathing and relaxation, the release of stress hormones such as adrenaline, which can increase the blood pressure drops. Improve blood circulation: Gentle movements stimulate the flow of blood in the small vessels and relieve the load on the heart. Strengthening of the respiratory muscles: A balanced breathing pattern, oxygen consumption, and can stabilize blood pressure. Awareness of their own body: The Exercises promote the perception of tensions and allow early against regulation. What the science says? Although individual patient reports, reports of positive experiences, a lack of large-scale, scientifically accepted studies that demonstrate the effectiveness of the Shishonina Gymnastics for high blood pressure clearly. Doctors recommend: Alternative methods can be a useful Supplement to conventional therapy, but not a replacement, so Dr. Petra Müller, is a cardiologist in Berlin. Before beginning any new exercise therapy, one should consult with his doctor. Conclusion The Shishonina Gymnastics offers may be gentle, to relax the body and sharpen the physical perception. As the sole method of treatment for high blood pressure is not recognized. You Wernt you as a part of a holistic approach — in combination with medical care, a healthy diet, and regular exercise — you can, however, contribute to quality of life. Caution: In the case of existing high blood pressure, always first consult the doctor before any new exercise programmes are launched.